<DOC>
	<DOCNO>NCT02570243</DOCNO>
	<brief_summary>This prospective , multi-center , superiority study parallel design . Patients enrol old 18 year old , schedule 5 6 Fr diagnostic coronary angiography interventional cardiologist willing proceed radial access . Patients randomize diagnostic catheterization receive intravenously either 100IU/Kg 50 IU/Kg unfractionated heparin ( UFH ) 1:1 ratio . Patients discharge usually within 4 6 hour coronary angiography . Radial artery patient evaluate either in-hospital subsequent visit one physician blind actual antithrombotic treatment give . Radial artery consider occlude exhibit ultrasonographically antegrade flow signal baseline reevaluation second occasion , within 30 day index procedure . Initially patent artery reexamine thought remain permanently patent . The investigator also monitor major bleeding ( define ≥ 5g/dL decrease hemoglobin ≥15 % decrease hematocrit life-threatening bleeding ( confirm MRI compute tomography ) large local hematoma forearm ( define extend beyond forearm ) .</brief_summary>
	<brief_title>High ( 100IU/Kg ) Versus Standard ( 50IU/Kg ) Heparin Dose Prevention Forearm Artery Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Older 18 year old Scheduled 5 6 Fr diagnostic coronary angiography The interventional cardiologist willing proceed radial access Written inform consent Before randomization chronic hemodialysis oral anticoagulation hemodynamic instability severe dermomyoskeletal forearm deformity history CABG bilateral use either internal mammary radial artery history CABG ipsilateral use internal mammary radial artery admission elective PCI After randomization crossover another arterial access site require ad hoc PCI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>heparin</keyword>
	<keyword>radial artery</keyword>
</DOC>